International Flavors & Fragrances Inc.

International Flavors & Fragrances Inc.

IFF

$92.18

Updated: 04/11/2026, 10:34:35

Market Cap
$23.52B
Sector
Basic Materials
Industry
Chemicals - Specialty
Country
US

No historical data available

Company Profile

International Flavors & Fragrances Inc. (IFF), through its various subsidiaries, operates as a global developer and purveyor of active cosmetic and natural health ingredients. These vital components are incorporated into a wide array of consumer goods distributed across significant markets such as Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. The company's activities are organized into four principal divisions: 1. Nourish: This segment focuses on natural and plant-derived specialty food ingredients, offering items like flavor compounds, savory solutions, and inclusions. It also provides natural food protection solutions, including antioxidants and anti-microbials, for use in beverages, confectionery, and dairy items. 2. Scent: The Scent division creates fragrance compounds, encompassing luxurious fine fragrances (perfumes and colognes) and everyday consumer fragrances. It further supplies essential fragrance ingredients, both synthetic and natural, which are blended to formulate new scents. Additionally, this segment delivers cosmetic active ingredients, such as functional compounds, botanicals, and advanced delivery systems, designed to enhance customers' cosmetic and personal care product lines. 3. Health & Biosciences: This segment is dedicated to the research, development, and production of enzymes, food cultures, probiotics, and other specialized biological ingredients. 4. Pharma Solutions: This division is responsible for manufacturing and distributing cellulosic and seaweed-derived pharmaceutical excipients. IFF's diverse customer base primarily consists of manufacturers in sectors including perfumery, cosmetics, hair and personal care, soaps and detergents, cleaning products, dairy, meat and processed foods, beverages, snacks and savory items, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional foods, and producers of pharmaceutical excipients and oral care products. Established in 1833, International Flavors & Fragrances Inc. is headquartered in New York, New York.

USD
NYSE
CEO: Jon Erik Fyrwald
Employees: 21,500
https://www.iff.com
Asset Summaries
Latest generated summaries for IFF

No summaries found.

Detailed business
Evidence-backed facts extracted from the latest official annual filing.
IFF-10-k-fy2025.html4.0 MBtext/htmlENFiled 27/02/2026Period ended 31/12/2025

Business monitoring

Reported and calculated KPIs plus operational exposure disclosed in the FY 2025 filing.

Evidence-backed · 61 KPI observations

Revenue

$10.9B

FY 2025 · Reported

Net income

$-0.4B

FY 2025 · Reported

Gross margin

36.2%

FY 2025 · Calculated

Free cash flow

$0.3B

FY 2025 · Calculated

R&D intensity

6.4%

FY 2025 · Calculated

Share repurchases

$0.0B

FY 2025 · Reported

Earnings and cash generation
USD billions, directly sourced from inline XBRL; free cash flow is operating cash flow less capex.
Profitability and reinvestment
Margins and R&D as a percentage of revenue.
Top products and services
Products and services mentioned in the filing; a quantitative sales breakdown was not disclosed.

Other offerings mentioned without separate sales

Scent segment composition

Area-level product sales are displayed only when the filing reports a product × geography breakdown. Regional totals are not allocated across products by estimation.

Geographic footprint
What the filing identifies, separated by location role so partner manufacturing is not presented as Apple-owned factories.
1 named headquarters
0 manufacturing countries
0 individually named factories

Map layer

Pins show disclosed operations. The heatmap colors the filing’s reported geographies; regional figures shade the region and are not estimates for each country.

No reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureUnited States: 28.0% of reported revenueNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosureNo reported geographic revenue disclosure
Named headquarters Manufacturing partner country

Only locations and quantities explicitly supported by the filing are displayed. A country-level manufacturing percentage or product allocation is shown only when the source discloses it; materiality scores are never presented as production shares.

Revenue exposure by reported geography
FY 2025 share of total net sales. Regional segments are kept as regions rather than falsely allocated to individual countries.
United States
+28.0%

How the business makes money

Business overview

Leading creator/manufacturer for food, beverage, health & biosciences, and scent

98%
Source evidence
“We are a leading creator and manufacturer of products for application in food, beverage, health & biosciences, and scent, as well as complementary adjacent products, including natural health ingredients”

Five reportable segments in 2025

Taste, Food Ingredients, Health & Biosciences, Scent; Pharma Solutions until May 2025; Nourish split into Taste and Food Ingredients effective Jan 1, 2025

98%
Source evidence
“During the year ended December 31, 2025, our business consisted of five segments: Taste, Food Ingredients, Health & Biosciences, Scent and, until the completion of the divestitures of both the Pharma Solutions and Nitrocellulose disposal groups in May 2025, Pharma Solutions.”

End-market customers

Manufacturers of dairy, meat, beverages, snacks, personal care, detergents, perfumes, supplements, animal nutrition, bio-fuel, oral care products

95%
Source evidence
“Our products are sold principally to manufacturers of dairy, meat, beverages, snacks, savory, sweet, baked goods, grain processors and other foods, personal care products, soaps and detergents”

Customer base size and mix

Approximately 20,000 customers in fiscal 2025; ~69% small and mid-sized companies

95%
Source evidence
“we had approximately 20,000 customers, approximately 69% of which are small and mid-sized companies”

Scent segment composition

Scent = Fragrance Compounds (fine + consumer fragrances) and Fragrance Ingredients sold to third parties including competitors

95%
Source evidence
“While the principal role of our fragrance ingredients facilities is to support our fragrance compounds business, we utilize excess manufacturing capacity to manufacture and sell certain fragrance ingredients to third parties, enabling us to leverage our fixed costs”

US share of sales 2025

U.S. ~28% of 2025 sales; no other country >10%

95%
Source evidence
“Our business is geographically diverse, with sales in the U.S. representing approximately 28% of sales in 2025. No other country represented more than 10% of sales.”

2025 segment net sales vs 2024/2023

2025: Taste $2,481M; Food Ingredients $3,278M; H&B $2,283M; Scent $2,479M; Pharma Solutions $369M; Total $10,890M

98%
Source evidence
“Taste$2,481 $2,428 $2,303 2 %5 % Food Ingredients3,278 3,365 3,692 (3)%(9)% Health & Biosciences2,283 2,203 2,071 4 %6 % Scent2,479 2,439 2,393 2 %2 % Pharma Solutions369 1,049 1,020 (65)%3 %”

Operations and dependencies

Manufacturing footprint

~170 manufacturing facilities, creative centers and application labs in ~30 countries

95%
Source evidence
“we had approximately 170 manufacturing facilities, creative centers and application laboratories located in approximately 30 different countries.”

Raw material sourcing scale

~20,000 different raw materials sourced from domestic and international suppliers/distributors

95%
Source evidence
“As of December 31, 2025, we sourced approximately 20,000 different raw materials from a broad network of domestic and international suppliers and distributors.”

Positioning and strategy

2026 capex guidance

Capital spending in 2026 expected to be approximately 6% of sales

90%
Source evidence
“We have evaluated and re-prioritized our capital projects and expect that capital spending in 2026 will be approximately 6% of sales.”

2025 divestitures of Pharma Solutions and Nitrocellulose

Pharma Solutions divested May 1, 2025; Nitrocellulose divested May 9, 2025; divestiture impact ~$757M on sales comparison

97%
Source evidence
“We completed the divestiture of our Pharma Solutions disposal group, which included certain adjacent businesses, on May 1, 2025 and we divested our nitrocellulose business, which was within our Pharma Solutions segment, on May 9, 2025.”

2025 divestitures

2025 divestitures: Pharma Solutions, Nitrocellulose, Tobacco Flavoring (North America), Rene Laurent (France)

95%
Source evidence
“higher net proceeds received from business divestitures, including the Pharma Solutions disposal group, the Nitrocellulose business, the Tobacco Flavoring business in North America, and the Rene Laurent business in France”

Core supplier list position with strategic customers

On core supplier lists of a large majority of global/strategic customers — key commercial success factor

93%
Source evidence
“A key factor for commercial success is our inclusion on strategic customers' core supplier lists, which provides opportunities to expand and win new business. We are on the core supplier lists of a large majority of our global and strategic customers.”

R&D scale and patents

~3,000 R&D employees; 849 granted U.S. patents; 2025 R&D $694M (6.4% of sales)

96%
Source evidence
“As of December 31, 2025, we have 849 granted U.S. patents, and 451 pending U.S. patent applications”

Risks, financing, and outlook

Raw material price management strategies

Contracts, hedging, indexed pricing, supplier relationships to manage raw material costs/supply

93%
Source evidence
“negotiating contracts with fixed or formula-based pricing for defined periods •hedging raw materials that can be linked to liquid commodity assets •building strategic supplier relationships to access critical materials”

Liquidity facilities and commercial paper

$2B undrawn Revolving Credit Facility; $314M commercial paper outstanding at Dec 31, 2025

95%
Source evidence
“we had $314 million of Commercial Paper outstanding. As of December 31, 2025, we had no borrowings outstanding under the Revolving Credit Facility.”

Senior Notes outstanding

$5.637B senior unsecured notes ($940M EUR, $4.697B USD), rates 1.56%-5.12%, maturities Sep 25, 2026-Dec 1, 2050

95%
Source evidence
“we had $5.637 billion aggregate principal amount outstanding in senior unsecured notes, with $940 million principal amount denominated in EUR and $4.697 billion principal amount denominated in USD”

EU microplastics ban

European Commission ban on microplastics requires reformulation of affected products

90%
Source evidence
“the European Commission’s ban on microplastics in personal care products, detergents, and cosmetics requires us to innovate and reformulate affected products.”

US TSCA new-substance challenges

TSCA presents significant challenges and delays for bringing new substances to market in the US

90%
Source evidence
“under the Toxic Substances Control Act (“TSCA”) chemicals regulation, companies experience significant challenges to bring new substances to the market”

Environmental compliance spending

Environmental compliance: $22M (2025) and $32M (2024) capex; $119M (2025) and $136M (2024) opex; CERCLA proceedings expected not material

90%
Source evidence
“we spent approximately $22 million and $32 million on capital projects and $119 million and $136 million in operating expenses and governmental charges, respectively, for the purpose of complying with such regulations”

EU Chemicals Strategy for Sustainability and related regulations

EU CSS driving updates to CLP and Detergent Regulation may negatively impact enzymes and fragrance ingredients

90%
Source evidence
“the European Green Deal’s Chemicals Strategy for Sustainability (“CSS”) has driven updates to key regulations such as the EU Classification, Labeling and Packaging regulation (“CLP”) and the EU Detergent Regulation”

Strategic transformation and portfolio divestiture risk

Company evaluating strategic alternatives for Food Ingredients segment as part of portfolio optimization

95%
Source evidence
“we have completed several divestitures in recent years and continue to evaluate additional transactions, including strategic alternatives for our Food Ingredients segment.”

Antitrust and competition investigations and litigation

Ongoing antitrust/competition investigations and related class action lawsuits could negatively impact results

95%
Source evidence
“Our results of operations may be negatively impacted by the outcome of uncertainties related to legal claims, disputes, investigations and litigation, including the ongoing antitrust and competition investigations and related class action lawsuits.”

Input cost inflation risk

Rising raw material, transportation, and energy costs exacerbated by inflationary pressures

95%
Source evidence
“Increases in input costs, including raw materials, transportation, and energy, have been exacerbated by recent inflationary pressures.”

Anti-bribery/corruption exposure in emerging markets

Operations in China, India, Brazil, Russia and certain African countries present elevated fraud/corruption risks under FCPA and similar laws

90%
Source evidence
“We operate and may pursue opportunities in jurisdictions such as China, India, Brazil, Russia, and certain African countries, which present elevated risks of fraud, corruption, and internal control challenges.”

Competitive intensity including customer in-housing

Intense global competition including consumer product companies developing their own alternatives

90%
Source evidence
“We face intense global competition from multinational and specialized companies across our product offerings, as well as consumer product companies developing their own alternatives.”

N&B Transaction tax indemnity to DuPont

N&B Transaction could result in significant tax liability; IFF may be obligated to indemnify DuPont

90%
Source evidence
“The N&B Transaction could result in significant tax liability, and we may be obligated to indemnify DuPont for any such tax liability imposed on DuPont.”

Customer core list dynamics

Customers rely on core lists of suppliers requiring favorable terms like rebates, pressuring margins

85%
Source evidence
“Multinational and increasingly middle market customers also rely on “core lists” of suppliers, requiring more favorable terms for inclusion, such as rebates, which could adversely affect our margins.”

Material exposure graph

Multinational consumer products companies
Customer Exposure

Top 25 customers, mostly multinational consumer products companies, account for ~32% of sales; their competitive pressures and core-list requirements affect IFF demand and margins.

Relevance 90·Dependency 70·Confidence 95
Source evidence
“our 25 largest customers, a majority of which were multinational consumer products companies, collectively accounted for approximately 32% of our sales.”
Natural and synthetic ingredients (~20,000 raw materials)
Raw Material Dependency

Products rely on both natural and synthetic ingredients sourced from ~20,000 raw materials; company mitigates via hedging, formula-based contracts and strategic supplier relationships.

Relevance 85·Dependency 80·Confidence 93
Source evidence
“Our products rely on both natural and synthetic ingredients. As of December 31, 2025, we sourced approximately 20,000 different raw materials from a broad network of domestic and international suppliers and distributors.”
Raw materials
Raw Material Dependency

Raw material, transportation, and energy cost increases, exacerbated by inflation, supply chain disruptions, trade wars and tariffs can adversely affect sourcing and results.

Relevance 85·Dependency 80·Confidence 90
Source evidence
“Increases in input costs, including raw materials, transportation, and energy, have been exacerbated by recent inflationary pressures.”
Consumer demand and preferences
Demand Driver

Demand depends on consumer preferences including weight-management pharmaceutical use, health/wellness awareness, labeling transparency, and macroeconomic conditions; customers can cancel or postpone orders on short notice.

Relevance 85·Dependency 75·Confidence 90
Source evidence
“the increasing use of weight management pharmaceutical products, increasing health and wellness awareness, greater transparency in product labeling”
Large multinational consumer products companies
Customer Exposure

Top 25 customers, mostly multinational consumer products companies, account for ~32% of sales; inclusion on core supplier lists is a key commercial success factor.

Relevance 85·Dependency 65·Confidence 95
Source evidence
“A significant portion of our sales comes from a relatively small number of large multinational customers.”
United States
Revenue Exposure

U.S. represents ~28% of 2025 sales; no other country exceeds 10%.

Relevance 80·Dependency 55·Confidence 95
Source evidence
“sales in the U.S. representing approximately 28% of sales in 2025. No other country represented more than 10% of sales.”
~170 facilities in ~30 countries
Manufacturing Dependency

Global manufacturing network across ~30 countries underpins supply; major sites in US, Netherlands, Spain, Germany, Indonesia, Turkey, Brazil, Mexico, China, India and others.

Relevance 75·Dependency 70·Confidence 92
Source evidence
“Our major manufacturing sites are located in the United States, The Netherlands, Spain, Germany, Indonesia, Turkey, Brazil, Mexico, Slovenia, China, India, Ireland, Norway, Finland, Denmark, Belgium and Singapore.”
EU microplastics ban
Regulatory Exposure

EU microplastics ban forces reformulation of personal care/detergent/cosmetics products, creating reformulation costs and potential product impacts.

Relevance 75·Dependency 60·Confidence 90
Source evidence
“the European Commission’s ban on microplastics in personal care products, detergents, and cosmetics requires us to innovate and reformulate affected products.”
Antitrust and competition laws
Legal Exposure

Ongoing antitrust/competition investigations and class action lawsuits could negatively impact results; competition authorities actively enforce in US, EU and other jurisdictions.

Relevance 75·Dependency 60·Confidence 90
Source evidence
“including the ongoing antitrust and competition investigations and related class action lawsuits.”
Wheat, corn and soy commodity crops
Raw Material Dependency

Natural ingredients derive partly from commodity crops like wheat, corn and soy used directly or as inputs for synthetic ingredients.

Relevance 70·Dependency 60·Confidence 90
Source evidence
“commodity crops like wheat, corn and soy. These materials contain diverse organic chemicals that are responsible for the fragrance, flavor, antioxidant properties and nutritional value.”
US Toxic Substances Control Act (TSCA)
Regulatory Exposure

TSCA review delays and restrictive conditions impede bringing new substances to the US market.

Relevance 70·Dependency 55·Confidence 90
Source evidence
“companies experience significant challenges to bring new substances to the market, with major delays experienced with US EPA assessments”
Foreign currency exposure
Currency Exposure

Currency fluctuation or devaluation in international markets may negatively affect results of operations.

Relevance 65·Dependency 55·Confidence 85
Source evidence
“The impact of currency fluctuation or devaluation in the international markets in which we operate may negatively affect our results of operations.”
US Dollar
Currency Exposure

$4.697 billion of senior notes denominated in USD.

Relevance 55·Dependency 40·Confidence 90
Source evidence
“$4.697 billion principal amount denominated in USD”
Euro
Currency Exposure

$940 million principal of senior notes denominated in EUR creates euro currency exposure on the debt side.

Relevance 55·Dependency 40·Confidence 90
Source evidence
“we had $5.637 billion aggregate principal amount outstanding in senior unsecured notes, with $940 million principal amount denominated in EUR”
Credit rating and borrowing costs
Cost Driver

Revolving Credit Facility pricing grids are based on credit rating; a downgrade would increase cost of borrowing.

Relevance 50·Dependency 40·Confidence 90
Source evidence
“our existing Revolving Credit Facility has pricing grids that are based on credit rating, such that our cost of borrowing may increase if our credit rating decreases.”
Full company information
Latest profile, trading, valuation, and identifier data stored for IFF.
Share price
$92.18
Market cap
$23.52B
Exchange
NYSE
Currency
USD
CEO
Jon Erik Fyrwald
Employees
21,500
IPO date
17/12/1974
Beta
0.879
Last dividend
$0.00
Day range
$91.64 – $94.42
52-week range
$61.30 – $95.27
1-day performance
-2.59%
1-year performance
50.38%
Current drawdown (1Y)
-3.24%
CIK
0000051253
CUSIP
459506101
ISIN
US4595061015
Created
07/12/2025, 04:41:20
Last update
04/11/2026, 10:34:35

Track International Flavors & Fragrances Inc. with an AI analyst

See which prediction-market events move IFF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to IFF from your Railway `news_articles` table.

LMR by IFF Inaugurates New Experimental Field in Grasse

Business Wire • STOCK • 28/05/2026, 07:00:00

Reasons Why You Should Retain IFF Stock in Your Portfolio Now

Zacks Investment Research • STOCK • 25/05/2026, 13:26:04

IFF Opens Vanilla Innovation Center in Madagascar

Business Wire • STOCK • 11/05/2026, 10:15:00

International Flavors & Fragrances Q1 Earnings Call Highlights

MarketBeat • STOCK • 10/05/2026, 22:05:32

LMR Naturals to Showcase Leadership in Natural Ingredients at SIMPPAR, the International Exhibition of Raw Materials for Perfumery

Business Wire • STOCK • 07/05/2026, 05:00:00

International Flavors & Fragrances Inc. (IFF) Q1 2026 Earnings Call Transcript

Seeking Alpha • STOCK • 06/05/2026, 14:21:17

IFF Q1 Earnings Beat Estimates on Volume Growth & Productivity Gains

Zacks Investment Research • STOCK • 06/05/2026, 11:11:05

Compared to Estimates, International Flavors (IFF) Q1 Earnings: A Look at Key Metrics

Zacks Investment Research • STOCK • 05/05/2026, 21:00:52

International Flavors & Fragrances beats quarterly sales and profit estimates

Reuters • STOCK • 05/05/2026, 19:18:47

International Flavors & Fragrances (NYSE: IFF) Stock Analysis: Barclays Rating, Price Target Adjustment, and Institutional Investor Sentiment

Market Data • Market Data • 14/04/2026, 15:11:21

IFF Launches PureStrong™, a Probiotic Made Specifically for Dogs

Business Wire • STOCK • 02/04/2026, 10:15:00

International Flavors (IFF) Down 14.1% Since Last Earnings Report: Can It Rebound?

Zacks Investment Research • STOCK • 13/03/2026, 13:36:59